We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Review · November 01, 2020

Risk of Deep Fungal Infections During IL-17 and IL-23 Inhibitor Therapy in Psoriasis

Cutaneous Medicine for the Practitioner

 

Additional Info

Cutaneous Medicine for the Practitioner
Risk for Deep Fungal Infections During IL-17 and IL-23 Inhibitor Therapy for Psoriasis
Cutis 2020 Oct 01;106(4)199-205, MP Lee, KK Wu, EB Lee, JJ Wu

Further Reading